GERSHOM DOUGLAS: Open Payments
NPI 1902568942 · SHELBY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$954 in 42 payments from 7 companies in 2025. Trend: 2023 $61 · 2024 $476 · 2025 $954
Food & beverage: $954
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 12 | $302 |
| AstraZeneca Pharmaceuticals LP | 12 | $248 |
| Calliditas Therapeutics US Inc. | 7 | $186 |
| AKEBIA THERAPEUTICS INC | 3 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Ardelyx, Inc. | 1 | $28 |
Products named: FARXIGA, TARPEYO, Vafseo, Kerendia, JYNARQUE, IBSRELA.
Industry payments across NC — which companies pay providers there.
